ZNF620 Activators are a distinct group of chemical compounds engineered to specifically target and enhance the activity of ZNF620, a member of the zinc finger protein family. Zinc finger proteins are characterized by their zinc finger motifs, which facilitate binding to DNA, RNA, or other proteins, playing pivotal roles in various cellular functions including gene expression, DNA recognition, and signal transduction. ZNF620, in particular, is thought to be involved in transcriptional regulation due to its zinc finger domains, which suggest its capability to interact with specific DNA sequences, thereby influencing the expression of target genes. The development of ZNF620 Activators is based on the premise that modulating the activity of ZNF620 could have significant implications for the transcriptional networks it regulates. These activators are synthesized through sophisticated chemical processes, aiming to produce molecules that can specifically interact with the ZNF620 protein, potentially enhancing its DNA-binding activity or its interaction with transcriptional machinery. The design of these compounds requires a deep understanding of the structure and function of ZNF620, including its DNA-binding domains and any regulatory regions that might be targeted to modulate the protein's activity effectively.
The research into ZNF620 Activators incorporates a multidisciplinary approach, utilizing methodologies from molecular biology, structural biology, and biochemistry. Scientists employ techniques such as electrophoretic mobility shift assays (EMSAs) and chromatin immunoprecipitation (ChIP) to study the DNA-binding activity of ZNF620 and to assess how activators influence this interaction. Additionally, reporter gene assays and RNA sequencing are used to evaluate the effects of ZNF620 activation on gene expression profiles, providing insights into the biological pathways regulated by ZNF620. Structural studies, including X-ray crystallography and NMR spectroscopy, are crucial for elucidating the three-dimensional structure of ZNF620, identifying potential binding sites for activators, and understanding the conformational changes associated with activation. Computational modeling and molecular docking further aid in predicting the interactions between ZNF620 and potential activators, guiding the rational design and optimization of these molecules for increased efficacy and specificity. Through this comprehensive research effort, the study of ZNF620 Activators aims to shed light on the regulatory mechanisms of gene expression mediated by zinc finger proteins, contributing to our broader understanding of transcriptional regulation and cellular signaling pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an HDAC inhibitor that can lead to chromatin remodeling and potentially influence gene expression by altering histone acetylation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can incorporate into DNA and RNA, leading to hypomethylation of DNA and potentially affecting the expression of various genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is another HDAC inhibitor that can affect gene expression by causing increased acetylation of histones. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can influence metabolic gene expression and potentially broader gene regulation networks. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences and could inhibit Sp1 transcription factor, affecting the expression of Sp1-regulated genes. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-azacytidine, decitabine is a DNA methyltransferase inhibitor that could lead to gene expression changes through DNA demethylation. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine is another DNA methyltransferase inhibitor, which may alter gene expression patterns by affecting DNA methylation status. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a non-nucleoside DNA methyltransferase inhibitor that could potentially modify the expression of genes by DNA demethylation. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
BIX-01294 is an inhibitor of G9a histone methyltransferase, which can influence gene expression by changing histone methylation states. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can chelate metal ions and inhibit various enzymes, which could indirectly affect gene expression. | ||||||